eMedicine Specialties > Dermatology > Mycobacterial Infections

Mycobacterium Marinum Infection of the Skin

Author: Joslyn Sciacca-Kirby, MD, Staff Physician, Department of Dermatology, Hospital of the University of Pennsylvania
Coauthor(s): Ellen Kim, MD, Assistant Professor, Department of Dermatology, Hospital of the University of Pennsylvania School of Medicine; Saeed Jaffer, MD, MS, Assistant Clinical Professor, University of California at Los Angeles School of Medicine, Consulting Staff, Boston Dermatology
Contributor Information and Disclosures

Updated: Sep 8, 2006

Introduction

Background

Mycobacterium marinum is an atypical Mycobacterium found in salt and fresh water. M marinum is the most common atypical Mycobacterium to cause infection in humans. Infection occurs following primary inoculation of a skin abrasion or puncture and manifests as a localized granuloma or sporotrichotic lymphangitis. Diagnosis and treatment are often delayed because of a lack of suspicion for mycobacterial involvement, ie, versus more common bacterial pathogens.

Pathophysiology

M marinum infection occurs following trauma to an extremity that is in contact with an aquarium, salt water, or marine animals such as fish or turtles. Exposure to M marinum via swimming pools is rare because most pools are chlorinated.

The pathogen is classified in Runyon group 1 and is a photochromogen, which means it produces yellow pigment when cultured and exposed to light. Culture growth occurs over 7-21 days and is optimal at 25-32°C (77-89.6°F) because the organism is adapted to infect ectotherms, such as fish. Endotherms, such as humans, also can be infected; however, the cooler extremities are affected more often than central sites. Systemic infection, usually in the context of an immunocompromised host, has been reported. This indicates that the organism is capable of adapting to grow in conditions closer to 37°C.

After inoculation into the host tissues via an abrasion or other wound, the mycobacteria are phagocytosed by macrophages. Inside the macrophage, they are able to interrupt the formation of the phagolysosome, which would kill the organisms. The mycobacteria then escape the lysosome and can move intracellularly and extracellularly via actin-based motility. This may contribute to cell-to-cell spread.

Studies have revealed 2 pathophysiologically and genetically (ie, via amplified restriction-based polymorphism analysis) distinct populations of M marinum. One group can infect humans and causes acutely lethal disease in fish, while a second group cannot infect humans and causes chronic progressive disease in fish.

Frequency

United States

Infections caused by M marinum are rare but well described in the literature. The estimated annual incidence is 0.27 cases per 100,000 adult patients. Of the approximately 150 cases described, most are case reports of cutaneous infection; however, some describe osteomyelitis, tenosynovitis, arthritis, and disseminated infection. Nosocomial infection has never been described.

International

Infection occurs worldwide, most commonly in individuals with occupational and recreational exposure to fresh or salt water.

Mortality/Morbidity

The disease typically remains localized and does not cause significant morbidity in patients who are immunocompetent. Cases reported in patients who are severely immunocompromised have resulted in disseminated infection involving the bone marrow and viscera and may result in death.

Race

No racial predilection is apparent.

Sex

No sexual predilection has been noted.

Age

M marinum infection has been reported in persons of every age group; however, it appears to be rare in the pediatric population.

Clinical

History

  • Patients at risk include anglers, oyster workers, swimmers, aquarium workers, and individuals with aquariums in their homes.
  • Patients may present with a papule, nodule, or ulcer at the site of trauma and a history of exposure to nonchlorinated water 2-3 weeks earlier. Patients may give a history of a papule or nodule that subsequently ulcerated and/or (1) signs of the infection spreading up the finger or hand or (2) involvement of the local joint or tendons. Over a period of months, localized cutaneous disease can spread to soft tissues.
  • Localized pain and induration are common. Fever, lymphadenopathy, and systemic infection are rare, with the exception of in immunosuppressed patients.

Physical

  • An erythematous or bluish 0.5- to 3-cm papule or nodule develops at the inoculation site, which is the upper extremity in 90% of cases. Ulceration can occur later, and subsequent lesions may be present along the path of lymphatic drainage of the extremity. This occurs in 25-50% of patients and is termed sporotrichotic spread.
  • Lymphadenopathy may be present.
  • Patients may have deeper involvement, with tenosynovitis bursitis, septic arthritis, and osteomyelitis of the underlying bone. Dissemination to the bone marrow and abdominal viscera is rare.
  • If diagnosis is delayed, the infections can mimic rheumatoid arthritis, gout, trauma-related tenosynovitis, foreign body, deep fungal infections, or malignancy.

Causes

The cause is infection with M marinum.

  • Exposure of traumatized skin to affected aqueous environments (fish tanks) is the leading predisposing factor.
  • Individuals who are consistently exposed to the organism are more likely to develop the infection.
  • Hosts who are immunocompromised are also at increased risk.

More on Mycobacterium Marinum Infection of the Skin

Overview: Mycobacterium Marinum Infection of the Skin
Differential Diagnoses & Workup: Mycobacterium Marinum Infection of the Skin
Treatment & Medication: Mycobacterium Marinum Infection of the Skin
Follow-up: Mycobacterium Marinum Infection of the Skin
References

References

  1. Arai H, Nakajima H, Kaminaga Y. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents. J Dermatol. Jun 1990;17(6):370-4. [Medline].

  2. Bhatty MA, Turner DP, Chamberlain ST. Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg. Mar 2000;53(2):161-5. [Medline].

  3. Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol. Jun 2005;44(6):518-20. [Medline].

  4. Donta ST, Smith PW, Levitz RE, Quintiliani R. Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin. Arch Intern Med. May 1986;146(5):902-4. [Medline].

  5. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med. Jun 27 1994;154(12):1359-64. [Medline].

  6. Garcia-Rodriguez JA, Gomez Garcia AC. In-vitro activities of quinolones against mycobacteria. J Antimicrob Chemother. Dec 1993;32(6):797-808. [Medline].

  7. Janik JP, Bang RH, Palmer CH. Case reports: successful treatment of Mycobacterium marinum infection with minocycline after complication of disease by delayed diagnosis and systemic steroids. J Drugs Dermatol. Sep-Oct 2005;4(5):621-4. [Medline].

  8. Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Infect Dis. Aug 2000;31(2):439-43. [Medline].

  9. Johnston JM, Izumi AK. Cutaneous Mycobacterium marinum infection ("swimming pool granuloma"). Clin Dermatol. Jul-Sep 1987;5(3):68-75. [Medline].

  10. Kent ML, Watral V, Wu M, Bermudez LE. In vivo and in vitro growth of Mycobacterium marinum at homoeothermic temperatures. FEMS Microbiol Lett. Apr 2006;257(1):69-75. [Medline].

  11. Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol. Apr 2006;33(4):817-9. [Medline].

  12. Ljungberg B, Christensson B, Grubb R. Failure of doxycycline treatment in aquarium-associated Mycobacterium marinum infections. Scand J Infect Dis. 1987;19(5):539-43. [Medline].

  13. Mahaisavariya P, Chaiprasert A, Manonukul J, et al. Detection and identification of Mycobacterium species by polymerase chain reaction (PCR) from paraffin-embedded tissue compare to AFB staining in pathological sections. J Med Assoc Thai. Jan 2005;88(1):108-13. [Medline].

  14. Noguchi M, Taniwaki Y, Tani T. Atypical Mycobacterium infections of the upper extremity. Arch Orthop Trauma Surg. Aug 27 2005;1-4. [Medline].

  15. Nolte O, Haag H, Häfner B. A mutation in the 65,000 Dalton heat shock protein gene, commonly used for molecular identification of non-tuberculous mycobacteria, leads to the misidentification of Mycobacterium malmoense as Mycobacterium marinum. Mol Cell Probes. Aug 2005;19(4):275-7. [Medline].

  16. Noonburg GE. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg. Jul-Aug 2005;13(4):243-53. [Medline].

  17. Oliver JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. Jun 2005;133(3):383-91. [Medline].

  18. Posteraro B, Sanguinetti M, Garcovich A, et al. Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection. Br J Dermatol. Nov 1998;139(5):872-6. [Medline].

  19. Ryan JM, Bryant GD. Fish tank granuloma--a frequently misdiagnosed infection of the upper limb. J Accid Emerg Med. Nov 1997;14(6):398-400. [Medline].

  20. Rybniker J, Kramme S, Small PL. Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis--application for identification and susceptibility testing. J Med Microbiol. Jan 2006;55(Pt 1):37-42. [Medline].

  21. Speight EL, Williams HC. Fish tank granuloma in a 14-month-old girl. Pediatr Dermatol. May-Jun 1997;14(3):209-12. [Medline].

  22. Stamm LM, Brown EJ. Mycobacterium marinum: the generalization and specialization of a pathogenic mycobacterium. Microbes Infect. Dec 2004;6(15):1418-28. [Medline].

  23. Wongworawat MD, Holtom P, Learch TJ, et al. A prolonged case of Mycobacterium marinum flexor tenosynovitis: radiographic and histological correlation, and review of the literature. Skeletal Radiol. Sep 2003;32(9):542-5. [Medline].

Further Reading

Keywords

tropical fish tank granuloma, fish tank granuloma, M marinum, Mycobacterium, Mycobacterium marinum, mycobacteria, acid-fast mycobacteria, saltwater infection, freshwater infection, marine infection, marine bacteria, water-borne bacteria, water-borne bacterial infection

Contributor Information and Disclosures

Author

Joslyn Sciacca-Kirby, MD, Staff Physician, Department of Dermatology, Hospital of the University of Pennsylvania
Joslyn Sciacca-Kirby, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, and Philadelphia County Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Ellen Kim, MD, Assistant Professor, Department of Dermatology, Hospital of the University of Pennsylvania School of Medicine
Ellen Kim, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Saeed Jaffer, MD, MS, Assistant Clinical Professor, University of California at Los Angeles School of Medicine, Consulting Staff, Boston Dermatology
Saeed Jaffer, MD, MS is a member of the following medical societies: American Academy of Dermatology and American Society for MOHS Surgery
Disclosure: Nothing to disclose.

Medical Editor

Terry L Barrett, MD, Director, Associate Professor, Department of Dermatology, Division of Dermatopathology and Oral Pathology, Johns Hopkins University School of Medicine
Terry L Barrett, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, College of American Pathologists, and United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory
Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, European Academy of Dermatology and Venereology, International Society of Dermatology, Massachusetts Medical Society, New York Academy of Sciences, Phi Beta Kappa, Society for Investigative Dermatology, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.